The Foundation for the NIH has announced the launch of a public-private partnership to advance knowledge of and accelerate drug development for individuals affected by amyotrophic lateral sclerosis.the Accelerating Medicines Partnership in Amyotrophic Lateral Sclerosis (AMP ALS), launched with roughly $60 million in funding, will combine resources and expertise of the National Institute of

Related Keywords

Julie Gerberding , Walter Koroshetz , Shenaz Bagha , Byrobert Herpen , Joe Biden , Medicines Partnership In Amyotrophic Lateral Sclerosis , Critical Path Institute , National Institute Of Neurological Disorders , Robert Herpen , Accelerating Medicines Partnership , Amyotrophic Lateral Sclerosis , National Institute , Neurological Disorders , Accelerating Access , Critical Therapies , President Joe Biden ,